Real Assets

Real Assets

We build future energy systems and resilient infrastructure, backing emerging opportunities in technology, land and water.

Latest news

News

InfraVia Announces the Creation of Supernova Power

Latest news

News

InfraVia Announces the Creation of Supernova Power

Featured insight

Insights

The next constraint on AI is not just energy - it's also water

Skip to main content

Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment. Take 2 mins to learn more. 

Overview

What is the Foresight Accelerated Inheritance Tax Solution?

The Foresight Accelerated Inheritance Tax Solution (Foresight Accelerated ITS) uniquely blends Business Relief (BR) and life insurance, giving investors immediate IHT mitigation. Since the Foresight Accelerated ITS was launched in 2016, over £300 million has been invested, with 99% of claims* having been successful

How does it work? 

The innovative solution works by investing in shares that should qualify for BR, which renders shares exempt from IHT after being held for two years. The integrated insurance cover is designed to give additional peace of mind during this initial two-year period.

*The remaining 1% consists of unsuccessful and/or pending claims.

Key documents

Sep 2025
Investor Guide
Sep 2025
Product Summary
Jun 2025
Latest factsheet
Jun 2018
Intermediary T&Cs

FAQs

Learn more about Foresight AITS
Contact us

Want to know more about our funds?

white-background dynamic-Image RippleV1-R1 RippleV1-R2 RippleV1-R3

You have viewed 0 of 0

Important information

Capital is at risk. The value of an investment, and any income from it can fall as well as rise and investors may not get back the full amount they invest. Foresight Inheritance Tax Solution (“ITS”), Accelerated Inheritance Tax Solution (“AITS”) and Enhanced Inheritance Tax Fund (“EITS”) should be considered longer-term investments and may be higher risk and more difficult to realise than an investment in listed securities. Investments will be made in small unquoted companies, which carry a higher risk than many other forms of investment. These investments will be illiquid and may expose you to a significant risk of losing all of the money you invest. Tax reliefs are dependent on investee companies continuing to qualify for Business Property Relief and investors’ individual circumstances. Current tax rules are subject to change. A failure to meet the BPR qualifying requirements could result in the investments losing their inheritance tax exempt status, resulting in adverse tax consequences for investors. 

AITS is a part of the ITS Fund and is an integrated Business Relief and insurance solution that gives investors immediate inheritance tax mitigation. For investment in the AITS Fund, insurance cover is only available to investors who meet the eligibility criteria for the relevant Insurance Category. Failure to meet such criteria or a misrepresentation in the eligibility declaration could result in the Insurer refusing to settle an investor’s claim under the Insurance Policy. 

Investors should only invest in ITS, AITS and EITS on the basis of information contained in the applicable Documentation (including any Brochure, Fund Prospectus, Offer Documents, Key Information Documents and Disclosure Documentation) or Terms and Conditions of Investment as appropriate. 

Please refer to our Risk Warnings page for full general and specific risk information. 

MICAP is part of Defaqto, an independent researcher of financial products and is not authorised to provide financial advice. Foresight does not have any influence or control over the Defaqto ratings or MICAP reviews including the methodology used. Foresight cannot accept responsibility for their accuracy and should not be relied upon for investment decisions. Ratings and reviews, including their use by Foresight, might be subject to change and are not indicative of any future performance. For further information on Defaqto and MICAP, please refer to the following resources: https://www.defaqto.com, www.micap.com/review/69 and www.micap.com/review/565

View Our Risk Warning